Table 2.

Efficiency of the first platelet transfusion in patients with thrombocytopenia receiving single or double doses of platelets



Total (n = 96)

AL patients (n = 29)

AT patients (n = 67)

Single dose
Double dose
P
Single dose
Double dose
P
Single dose
Double dose
P
Platelet count increment, 109/L   20.8 ± 13.5   44.5 ± 23.5   .001   22.6 ± 17.8   43.0 ± 18.4   .008   19.8 ± 10.4   45.0 ± 25.1   .001  
CCI
 
10.6 ± 5.4
 
12.5 ± 5.8
 
.116
 
12.3 ± 7.7
 
12.0 ± 5.2
 
.896
 
9.6 ± 3.6
 
12.6 ± 6.0
 
.025
 


Total (n = 96)

AL patients (n = 29)

AT patients (n = 67)

Single dose
Double dose
P
Single dose
Double dose
P
Single dose
Double dose
P
Platelet count increment, 109/L   20.8 ± 13.5   44.5 ± 23.5   .001   22.6 ± 17.8   43.0 ± 18.4   .008   19.8 ± 10.4   45.0 ± 25.1   .001  
CCI
 
10.6 ± 5.4
 
12.5 ± 5.8
 
.116
 
12.3 ± 7.7
 
12.0 ± 5.2
 
.896
 
9.6 ± 3.6
 
12.6 ± 6.0
 
.025
 

After the first transfusion, patients receiving a double dose of platelets had increased platelet count increments. CCI was calculated as a median time (time from the first transfusion to the next platelet count control) of 23 hours 45 minutes (minimum, 5 hours 56 minutes; maximum, 26 hours 45 minutes) for the arm A group (single dose) and 24 hours 00 minutes (minimum, 11 hours 30 minutes; maximum, 29 hours 00 minutes) for the arm B group (double dose; P = .097). With a double dose, the CCI was increased only in patients with AT but remained within a normal range (> 7), which demonstrates good efficiency in every group. Results are expressed as mean ± SD. Because of missing data, analyses were performed in 90 patients for the platelet count increment and 89 for the CCI.

Close Modal

or Create an Account

Close Modal
Close Modal